Go Pro
→ Your 10X AI demo is starting… (From TradeSmith) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Axe Compute Inc stock logo
AGPU
Axe Compute
$8.27
-1.0%		$7.49
$1.03
▼
$32.10
$95.06M3.44632,207 shs236,072 shs
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
$20.93
+1.5%		$21.40
$3.01
▼
$30.00
$74.58M1213,151 shs99,789 shs
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$8.27
-1.0%		$7.49
$0.71
▼
$16.54
$28.07M1.35473,545 shs237,702 shs
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
$4.87
+6.1%		$4.57
$1.20
▼
$6.86
$61.01M-0.7687,267 shs575,698 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Axe Compute Inc stock logo
AGPU
Axe Compute
0.00%-1.55%+22.34%+41.37%+826,999,900.00%
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
0.00%0.00%-18.59%+21.69%+552.02%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-0.96%-1.55%+19.16%+41.37%-36.63%
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
0.00%+20.54%+24.55%+7.27%+486,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Axe Compute Inc stock logo
AGPU
Axe Compute
$8.27
-1.0%		$7.49
$1.03
▼
$32.10
$95.06M3.44632,207 shs236,072 shs
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
$20.93
+1.5%		$21.40
$3.01
▼
$30.00
$74.58M1213,151 shs99,789 shs
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$8.27
-1.0%		$7.49
$0.71
▼
$16.54
$28.07M1.35473,545 shs237,702 shs
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
$4.87
+6.1%		$4.57
$1.20
▼
$6.86
$61.01M-0.7687,267 shs575,698 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Axe Compute Inc stock logo
AGPU
Axe Compute
0.00%-1.55%+22.34%+41.37%+826,999,900.00%
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
0.00%0.00%-18.59%+21.69%+552.02%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-0.96%-1.55%+19.16%+41.37%-36.63%
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
0.00%+20.54%+24.55%+7.27%+486,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Axe Compute Inc stock logo
AGPU
Axe Compute
1.00
SellN/AN/A
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
1.50
Reduce$6.00-71.33% Downside
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
1.00
SellN/AN/A
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
2.00
Hold$10.00105.34% Upside

Current Analyst Ratings Breakdown

Latest POAI, AGPU, CHRN, and VIVO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/13/2026
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
Noble Financial logo
Noble Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$10.00
6/23/2026
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/4/2026
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/1/2026
Axe Compute Inc stock logo
AGPU
Axe Compute
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 8/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Axe Compute Inc stock logo
AGPU
Axe Compute
$120K791.85N/AN/A$11.69 per share0.71
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
$12.80M5.82N/AN/A$3.44 per share6.08
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$1.66M16.86N/AN/A($0.46) per share-17.98
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
$60K1,017.02N/AN/A$1.60 per share3.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Axe Compute Inc stock logo
AGPU
Axe Compute
-$233.10M-$8.18N/AN/AN/A-470,383.31%-7,363.67%-626.32%N/A
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
-$11.69M-$5.38N/AN/AN/A-135.66%-197.81%-74.17%N/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-$12.66M-$13.50N/AN/AN/A-5,065.23%-732.73%-235.55%N/A
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
-$12.79MN/AN/AN/AN/AN/AN/AN/AN/A

Latest POAI, AGPU, CHRN, and VIVO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Axe Compute Inc stock logo
AGPU
Axe Compute
N/A-$0.87N/A-$0.87N/AN/A
6/30/2026Q2 2026
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
N/A-$3.8930N/A-$3.8930N/A$18.09 million
6/26/2026Q2 2026
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
N/A-$0.23N/A-$0.23N/A$0.01 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Axe Compute Inc stock logo
AGPU
Axe Compute
N/AN/AN/AN/AN/A
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
N/AN/AN/AN/AN/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/AN/A
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Axe Compute Inc stock logo
AGPU
Axe Compute
N/A
8.89
8.89
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
0.25
1.55
1.03
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/A
0.01
0.01
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Axe Compute Inc stock logo
AGPU
Axe Compute
9.04%
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
6.42%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
9.04%
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
15.80%

Insider Ownership

CompanyInsider Ownership
Axe Compute Inc stock logo
AGPU
Axe Compute
1.21%
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
6.90%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
1.21%
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
2.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Axe Compute Inc stock logo
AGPU
Axe Compute
1311.49 million11.36 millionN/A
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
603.56 million3.32 millionNo Data
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
303.39 million3.35 millionNot Optionable
VivoPower PLC Ordinary Shares stock logo
VIVO
VivoPower PLC Ordinary Shares
4112.53 million12.24 millionN/A

Recent News About These Companies

VivoPower PLC Ordinary Shares (NASDAQ:VIVO) Trading Up 2.8% – Should You Buy?
August 12, 2026  |  defenseworld.netD
VivoPower PLC Ordinary Shares (NASDAQ:VIVO) Trading Up 2.8% - Time to Buy?
August 12, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30955658
VivoPower clears $28.8m founder loan ahead of Nordic data centre push
August 3, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1096454?snapi
VivoPower Fully Retires US$28.8 Million Shareholder Debt Principal, Strengthening Balance Sheet Ahead of Nordic AI Infrastructure Buildout
August 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/03/3337531/0/en/vivopower-fully-retires-us-28-8-million-shareholder-debt-principal-strengthening-balance-sheet-ahead-of-nordic-ai-infrastructure-buildout.html
VivoPower secures $50M investment led by Blue Sky Capital to fund AI data center project
July 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/technology/ai/articles/vivopower-secures-50m-pipe-led-122900759.html
VivoPower secures $50M PIPE led by Blue Sky Capital to fund AI data center project
July 29, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1096208?snapi
VivoPower Secures US$50 Million PIPE At US$7.50 Conversion Price Per Share
July 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/29/3335190/0/en/vivopower-secures-us-50-million-pipe-at-us-7-50-conversion-price-per-share.html
VivoPower announces appointment of Group Finance Director
July 20, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1095707?snapi
VivoPower Appoints Group Finance Director
July 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/20/3329778/0/en/vivopower-appoints-group-finance-director.html
VivoPower positions for scarcity of renewable-backed AI compute sites
July 15, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1095505?snapi
Noble Capital Markets Initiates Equity Research Coverage on VivoPower
July 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/13/3326388/0/en/noble-capital-markets-initiates-equity-research-coverage-on-vivopower.html
VivoPower earns Outperform rating as Noble bets on "power-first" AI strategy
July 13, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1095351?snapi
VivoPower eyes potential earnings boost from battery storage at Norway data center
July 6, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1095003?snapi
VivoPower Targets Up To USD$4 million Incremental Annualized EBITDA from Battery Energy Storage Integration at Norway Data Center
July 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/06/3322702/0/en/vivopower-targets-up-to-usd-4-million-incremental-annualized-ebitda-from-battery-energy-storage-integration-at-norway-data-center.html
VivoPower sharpens AI data center focus, updates separation plans for two units
July 3, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1094919?snapi
VivoPower Reinforces Focus on AI Data Center Business and Provides Update on Non-Core Businesses
July 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/02/3321602/0/en/vivopower-reinforces-focus-on-ai-data-center-business-and-provides-update-on-non-core-businesses.html
VivoPower PLC Class A
June 30, 2026  |  cnn.comhttps://www.cnn.com/markets/stocks/VIVO
VivoPower PLC. - Ordinary Shares - Class A
June 29, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/vivo-vivopower-plc-ordinary-shares-class-a/vitals
VivoPower selects preferred tenant for Norway AI data center
June 29, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1094648?snapi
Correction: VivoPower Selects Global AI Industry Leader as Preferred Tenant for Lease of Norway Operational Data Center
June 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/29/3318877/0/en/correction-vivopower-selects-global-ai-industry-leader-as-preferred-tenant-for-lease-of-norway-operational-data-center.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Axe Compute stock logo

Axe Compute NASDAQ:AGPU

$8.27 -0.08 (-0.96%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$8.34 +0.07 (+0.79%)
As of 08/14/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

ChronoScale Corporation Common Stock stock logo

ChronoScale Corporation Common Stock NASDAQ:CHRN

$20.93 +0.31 (+1.50%)
As of 08/14/2026 04:00 PM Eastern

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Predictive Oncology stock logo

Predictive Oncology NASDAQ:POAI

$8.27 -0.08 (-0.96%)
As of 08/14/2026

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

VivoPower PLC Ordinary Shares stock logo

VivoPower PLC Ordinary Shares NASDAQ:VIVO

$4.87 +0.28 (+6.10%)
As of 08/14/2026 04:00 PM Eastern

VivoPower PLC is engaged in building, owning, and leasing powered land and data center infrastructure for AI compute applications. The group delivers specialized infrastructure solutions across the AI Data Centers, Power-to-X, and Electric Mobility. It is develop and operated infrastructure that enables sovereign nations and institutional partners to secure control over power, data, and national intelligence, supporting AI, compute-intensive workloads, and energy transition use cases.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas